Pre Transplantation Melanoma

Overview

Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma. There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet. Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.

Full Title of Study: “Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: August 31, 2020

Interventions

  • Other: patient with melanoma pre transplantation
    • survival time without melanoma recurrence

Clinical Trial Outcome Measures

Primary Measures

  • survival time without melanoma recurrence
    • Time Frame: at enrollment
    • Delay in recurrence-free survival since diagnosis and since transplantation

Participating in This Clinical Trial

Inclusion Criteria

  • patient with an antecedent of melanoma before transplantation – Not opposite to participate Exclusion Criteria:

  • Under the age of 18 – patient under Guardianship – patient not affiliated with a health system

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hospices Civils de Lyon
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Emilie DUCROUX, MD, Principal Investigator, Service de Dermatologie, Hôpital Edouard Herriot, Lyon

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.